SE9702595D0 - new therapeutic use - Google Patents

new therapeutic use

Info

Publication number
SE9702595D0
SE9702595D0 SE9702595A SE9702595A SE9702595D0 SE 9702595 D0 SE9702595 D0 SE 9702595D0 SE 9702595 A SE9702595 A SE 9702595A SE 9702595 A SE9702595 A SE 9702595A SE 9702595 D0 SE9702595 D0 SE 9702595D0
Authority
SE
Sweden
Prior art keywords
therapeutic use
new therapeutic
new
therapeutic
Prior art date
Application number
SE9702595A
Other languages
Swedish (sv)
Inventor
Harriet Roennholm
Christina Reuterdahl
Axel Staahlbom
Antek Wielburski
Thomas Olin
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9702595A priority Critical patent/SE9702595D0/en
Publication of SE9702595D0 publication Critical patent/SE9702595D0/en
Priority to AT98932685T priority patent/ATE209042T1/en
Priority to ES98932685T priority patent/ES2168772T3/en
Priority to EP98932685A priority patent/EP1007085B1/en
Priority to PT98932685T priority patent/PT1007085E/en
Priority to DE69803298T priority patent/DE69803298T2/en
Priority to DK98932685T priority patent/DK1007085T3/en
Priority to SI9830100T priority patent/SI1007085T1/en
Priority to JP50702099A priority patent/JP2002511876A/en
Priority to PCT/SE1998/001261 priority patent/WO1999001151A1/en
Priority to CA002294824A priority patent/CA2294824A1/en
Priority to NZ501961A priority patent/NZ501961A/en
Priority to AU82506/98A priority patent/AU737065B2/en
Priority to NO20000007A priority patent/NO20000007L/en

Links

SE9702595A 1997-07-04 1997-07-04 new therapeutic use SE9702595D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9702595A SE9702595D0 (en) 1997-07-04 1997-07-04 new therapeutic use
AU82506/98A AU737065B2 (en) 1997-07-04 1998-06-26 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase B (PKB) activity
DK98932685T DK1007085T3 (en) 1997-07-04 1998-06-26 Use of growth hormone in preparations for the treatment of insulin resistance in the heart
ES98932685T ES2168772T3 (en) 1997-07-04 1998-06-26 USE OF HORMONE OF GROWTH IN COMPOSITIONS FOR THE TREATMENT OF HEART RESISTANCE TO INSULIN.
EP98932685A EP1007085B1 (en) 1997-07-04 1998-06-26 Use of growth hormone in compositions for treating insulin resistance in the heart
PT98932685T PT1007085E (en) 1997-07-04 1998-06-26 USES OF GROWTH HORMONE IN COMPOSITIONS FOR THE TREATMENT OF INSULIN RESISTANCE IN THE HEART
DE69803298T DE69803298T2 (en) 1997-07-04 1998-06-26 USE OF GROWTH HORMONE IN AGENTS FOR TREATING INSULIN RESISTANCE IN THE HEART
AT98932685T ATE209042T1 (en) 1997-07-04 1998-06-26 USE OF GROWTH HORMONE IN AGENTS FOR TREATING INSULIN RESISTANCE IN THE HEART
SI9830100T SI1007085T1 (en) 1997-07-04 1998-06-26 Use of growth hormone in compositions for treating insulin resistance in the heart
JP50702099A JP2002511876A (en) 1997-07-04 1998-06-26 Use of growth hormone in a composition for treating insulin resistance in the heart and enhancing protein kinase B (PKB) activity
PCT/SE1998/001261 WO1999001151A1 (en) 1997-07-04 1998-06-26 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity
CA002294824A CA2294824A1 (en) 1997-07-04 1998-06-26 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity
NZ501961A NZ501961A (en) 1997-07-04 1998-06-26 A therapy for improving cellular function in a heart challenged by insulin resistance, thereby protecting the heart from complications arising from this condition
NO20000007A NO20000007L (en) 1997-07-04 2000-01-03 Use of growth hormone in compositions to treat insulin resistance in the heart and to increase protein kinase B (PKB) activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702595A SE9702595D0 (en) 1997-07-04 1997-07-04 new therapeutic use

Publications (1)

Publication Number Publication Date
SE9702595D0 true SE9702595D0 (en) 1997-07-04

Family

ID=20407648

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702595A SE9702595D0 (en) 1997-07-04 1997-07-04 new therapeutic use

Country Status (1)

Country Link
SE (1) SE9702595D0 (en)

Similar Documents

Publication Publication Date Title
ID24118A (en) COMBINED THERAPY
NO992806L (en) Therapeutic agents
IS5425A (en) Medicament
ID27841A (en) THERAPEUTIC BIARILS
DE69826299D1 (en) INHALER
IS2703B (en) inhaler
DE69825982D1 (en) SYRINGE
NO993393L (en) Photochemical therapeutic mixtures
ID24275A (en) COMBINATION THERAPY
PT1036083E (en) NEW 9A-AZALIDOS
DE69833493D1 (en) TISSUE
FR2763507B1 (en) INHALER
NO983090D0 (en) Therapeutic compounds
DE69824327D1 (en) inhaler
DK0983266T3 (en) New tetrahydrosioquinolinthiophenecarboximidamides
DE29712035U1 (en) Therapy device
DE29703038U1 (en) sauna
DE29710613U1 (en) Massager
DE69812879D1 (en) PATIENTS LIEGE
SE9702595D0 (en) new therapeutic use
DE29704427U1 (en) Filter-fan unit
SE9802023D0 (en) New therapeutic use
DE29710812U1 (en) Massager
SE9703483D0 (en) New use
ID19095A (en) THERAPEUTIC COMPOUNDS FENETANOLAMINA